and I–L show Untreated, drug alone, Drug+inhibitor and Inhibitor alone treated cell populations of MCF7 SCAT3, SCAT8 and SCAT 9 cells respectively. Cells were subjected to drug treatment in the following manner: MCF7 SCAT3 and SCAT9 cells with Staurosporine (250 nM) and SCAT8 cells with Anisomycin (2 mg/ml) for 10 hours. (TIF) Figure S4 Well positions of drugs (Supplementary informa- tion to Figure 7) Well positions in 96 well format of the drugs used for kinetics study of caspase activation and chromatin condensa- tion in HeLa SCAT3 cells. Detailed information on Drug concentrations used and the mechanism of action of drugs is given in Supplementary Table 2. (TIF) List of cell lines used in the study. Table S1 (DOC) References 1. Green DR, Evan GI (2002) A matter of life and death. Cancer Cell 1: 19–30. 2. Green DR (2005) Apoptotic pathways: ten minutes to dead. Cell 121: 671–674. 3. Berghe TV, Vanlangenakker N, Parthoens E, Deckers W, Devos M, et al. (2010) Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features. Cell Death Differ 17: 922–930. 4. Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239–257. 5. Sperandio S, de Belle I, Bredesen DE (2000) An alternative, nonapoptotic form of programmed cell death. Proceedings of the National Academy of Sciences 97: 14376–14381. 6. Degterev A, Yuan J (2008) Expansion and evolution of cell death programmes. Nat Rev Mol Cell Biol 9: 378–390. 7. Goldstein JC, Waterhouse NJ, Juin P, Evan GI, Green DR (2000) The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nat Cell Biol 2: 156–162. 8. Hao Z, Duncan GS, Chang CC, Elia A, Fang M, et al. (2005) Specific ablation of the apoptotic functions of cytochrome C reveals a differential requirement for cytochrome C and Apaf-1 in apoptosis. Cell 121: 579–591. 9. Heiskanen KM, Bhat MB, Wang HW, Ma J, Nieminen AL (1999) Mitochondrial depolarization accompanies cytochrome c release during apoptosis in PC6 cells. J Biol Chem 274: 5654–5658. 10. Lovell JF, Billen LP, Bindner S, Shamas-Din A, Fradin C, et al. (2008) Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax. Cell 135: 1074–1084. 11. Hoeppner DJ, Hengartner MO, Schnabel R (2001) Engulfment genes cooperate with ced-3 to promote cell death in Caenorhabditis elegans. Nature 412: 202–206. 12. Wei MC, Zong W-X, Cheng EH-Y, Lindsten T, Panoutsakopoulou V, et al. (2001) Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death. Science 292: 727–730. 13. Huang S (2009) Non-genetic heterogeneity of cells in development: more than just noise. Development 136: 3853–3862. 14. Snijder B, Pelkmans L (2011) Origins of regulated cell-to-cell variability. Nat Rev Mol Cell Biol 12: 119–125. 15. Spencer SL, Gaudet S, Albeck JG, Burke JM, Sorger PK (2009) Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature 459: 428–432. 16. Rehm M, Du¨ßmann H, Ja¨nicke RU, Tavare´ JM, Ko¨gel D, et al. (2002) Single- cell Fluorescence Resonance Energy Transfer Analysis Demonstrates That Caspase Activation during Apoptosis Is a Rapid Process. Journal of Biological Chemistry 277: 24506–24514. 17. He L, Wu X, Meylan F, Olson DP, Simone J, et al. (2004) Monitoring caspase activity in living cells using fluorescent proteins and flow cytometry. Am J Pathol 164: 1901–1913. 18. Levsky JM, Shenoy SM, Pezo RC, Singer RH (2002) Single-cell gene expression profiling. Science 297: 836–840. High Content Ratio Imaging for Apoptosis Detection Table S2 (DOC) Acknowledgments Details of drugs used in the study. We thank Dr. Masayuki Miura and Dr. Markus Rehm for the kind gift of the expression vectors used in the experiments; Prof M. Radhakrishna Pillai for continued support; Mrs Indu Ramachandran, Mr Saravanan for the FACS analyses; Mrs Jiji V for the confocal experiments; Saneesh Varghese and Prakash R for their skillful technical support. We also thank Dr. Paresh Jain, Scientific Advisor, BD Biosciences India, for his support in the analysis of HTS data. Author Contributions Conceived and designed the experiments: STR. Performed the experi- ments: STR JJ MS. Analyzed the data: STR JJ PKS. Contributed reagents/materials/analysis tools: STR. Wrote the paper: STR JJ. 19. Sigal A, Milo R, Cohen A, Geva-Zatorsky N, Klein Y, et al. (2006) Variability and memory of protein levels in human cells. Nature 444: 643–646. 20. Kasibhatla S, Tseng B (2003) Why target apoptosis in cancer treatment? Mol Cancer Ther 2: 573–580. 21. Lowe SW, Lin AW (2000) Apoptosis in cancer. Carcinogenesis 21: 485–495. 22. Johnstone RW, Ruefli AA, Lowe SW (2002) Apoptosis: A Link between Cancer Genetics and Chemotherapy. Cell 108: 153–164. 23. Vichai V, Kirtikara K (2006) Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protocols 1: 1112–1116. 24. Bates SE, Fojo AT, Weinstein JN, Myers TG, Alvarez M, et al. (1995) Molecular targets in the National Cancer Institute drug screen. Journal of Cancer Research and Clinical Oncology 121: 495–500. 25. Riedl SJ, Shi Y (2004) Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5: 897–907. 26. Jones J, Heim R, Hare E, Stack J, Pollok BA (2000) Development and Application of a GFP-FRET Intracellular Caspase Assay for Drug Screening. Journal of Biomolecular Screening 5: 307–317. 27. Huitema C, Eltis LD (2010) A Fluorescent Protein-Based Biological Screen of Proteinase Activity. Journal of Biomolecular Screening 15: 224–229. 28. Tian H, Ip L, Luo H, Chang DC, Luo KQ (2007) A high throughput drug screen based on fluorescence resonance energy transfer (FRET) for anticancer activity of compounds from herbal medicine. British Journal of Pharmacology 150: 321–334. 29. Sharma SV, Haber DA, Settleman J (2010) Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents. Nat Rev Cancer 10: 241–253. 30. Takemoto K, Nagai T, Miyawaki A, Miura M (2003) Spatio-temporal activation of caspase revealed by indicator that is insensitive to environmental effects. The Journal of Cell Biology 160: 235–243. 31. Angres B, Steuer H, Weber P, Wagner M, Schneckenburger H (2009) A membrane-bound FRET-based caspase sensor for detection of apoptosis using fluorescence lifetime and total internal reflection microscopy. Cytometry Part A 75A: 420–427. 32. Lei X, Chen Y, Du G, Yu W, Wang X, et al. (2006) Gossypol induces Bax/Bak- independent activation of apoptosis and cytochrome c release via a conformational change in Bcl-2. The FASEB Journal 20: 2147–2149. 33. Grankvist K (1989) Gossypol-induced free radical toxicity to isolated islet cells. International Journal of Biochemistry 21: 853–856. 34. de Peyster A, Quintanilha A, Packer L, Smith MT (1984) Oxygen radical formation induced by gossypol in rat liver microsomes and human sperm. Biochemical and Biophysical Research Communications 118: 573–579. 35. Mukhopadhyay P, Rajesh M, Hasko G, Hawkins BJ, Madesh M, et al. (2007) Simultaneous detection of apoptosis and mitochondrial superoxide production in live cells by flow cytometry and confocal microscopy. Nat Protocols 2: 2295–2301. 36. Galperin E, Verkhusha VV, Sorkin A (2004) Three-chromophore FRET microscopy to analyze multiprotein interactions in living cells. Nat Meth 1: 209–217. PLoS ONE | www.plosone.org 17 May 2011 | Volume 6 | Issue 5 | e20114